CCM
PMD

Copeland Capital Management’s Psychemedics Corporation PMD Stock Holding History

Copeland Capital Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-760
Closed -$8K – 313
2019
Q2 		$8K Hold
760
– – ﹤0.01% 221
2019
Q1 		$11K Buy
760
+56
+8% +$963 ﹤0.01% 210
2018
Q4 		$11K Buy
+704
New +$12.1K ﹤0.01% 198

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Copeland Capital Management's PMD Position: Q3 2019 in Review

Copeland Capital Management sold out of Psychemedics Corporation (PMD) in Q3 2019, closing a stake of 760 shares — an estimated $8K sold.

Copeland Capital Management first reported a position in PMD in Q4 2018 and held it in 3 quarters. The position peaked at $11K in Q1 2019. 45 funds tracked by Wall St. Rank hold PMD as of Q3 2019.

  • Copeland Capital Management reported no remaining Psychemedics Corporation position as of Q3 2019 after selling out during the quarter.
  • Copeland Capital Management sold 760 Psychemedics Corporation shares in Q3 2019, an estimated $8K.
  • Copeland Capital Management first reported a position in Psychemedics Corporation in Q4 2018 and held it in 3 quarters.
  • Copeland Capital Management's Psychemedics Corporation position peaked at $11K in Q1 2019.
  • 45 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2019.

Based on Copeland Capital Management's 13F filing for Q3 2019, filed 6 Nov 2019.